Fundz

Oto Nexus Medical Technologies, Inc. reported raising $12.9 Million in an initial SEC Form D filing, from an offering of $8.27 Million

PRIVATEJan 11, 2019

Amount Raised

$12.9 Million

$12.9 Million sold, per SEC Form D (first sale Jan 11, 2019)

Round Type

Seed

BellevueHealthcare

Quick answer

OtoNexus Medical Technologies, Inc. raised $12.9 Million in a Seed round, dated January 11, 2019. OtoNexus Medical Technologies, Inc. is based in Bellevue, Washington, United States.

How much did OtoNexus Medical Technologies, Inc. raise?
OtoNexus Medical Technologies, Inc. raised $12.9 Million in a Seed round on January 11, 2019.
What does OtoNexus Medical Technologies, Inc. do?
OtoNexus is developing the world’s first medical device to provide objective diagnostic data to instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults.
Where is OtoNexus Medical Technologies, Inc. based and how big is it?
OtoNexus Medical Technologies, Inc. is based in Bellevue, Washington, United States.
Who are the decision-makers at OtoNexus Medical Technologies, Inc?
Fundz holds 1 contact at OtoNexus Medical Technologies, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as OtoNexus Medical Technologies, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • RealTime Laboratories, Inc. raised $140K (Pre-Seed) on February 25, 2019.
  • First 24 Health Inc. raised an undisclosed amount on February 25, 2019.
  • IMPEL NEUROPHARMA INC raised an undisclosed amount on February 22, 2019.
  • BTG PLC raised $4.1M (Seed) on February 22, 2019.
  • InterRad Medical, Inc. raised $125K (Pre-Seed) on February 22, 2019.
  • X-Cor Therapeutics Inc. raised $200K (Pre-Seed) on February 21, 2019.

Who to call at OtoNexus Medical Technologies, Inc., and when

A new round usually means OtoNexus Medical Technologies, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OtoNexus Medical Technologies, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OtoNexus Medical Technologies, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OtoNexus Medical Technologies, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OtoNexus Medical Technologies, Inc.

Location

1546 NW 56TH STREET

Bellevue, Washington, United States

About

OtoNexus is developing the world’s first medical device to provide objective diagnostic data to instantly and accurately diagnose middle ear infections (Otitis Media) in children and adults. A simple and elegant solution, the device applies a well-known medical technology, ultrasound, in a completely novel way to achieve a key advance in differentiating when and when not to prescribe antibiotics. One-use-per-patient tips create a recurring revenue stream. The device will provide data in seconds and will be easy to use by physicians or non-physician personnel (NPs, PAs). Definitive, objective data identifying both the presence and the type of fluid behind the eardrum will lead to better outcomes and significantly reduced healthcare costs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OtoNexus Medical Technologies, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCaitlin C., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for OtoNexus Medical Technologies, Inc.'s next move

See what Strategic adds

OtoNexus Medical Technologies, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.